Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan 750004, China.
Ningxia Research Center of Modern Hui Medicine Engineering and Technology; Yinchuan 750004, China.
Molecules. 2018 May 16;23(5):1194. doi: 10.3390/molecules23051194.
Genus L. belongs to the family Asclepiadaceae, which comprise more than 200 species distributed worldwide. In Chinese medical practice, numerous drugs (such as tablets and powders) containing different parts of plants of this genus are used to treat snake bites, bruises, osteoblasts, rheumatoid arthritis and tumors. A search for original articles published on the cynanchum genus was performed by using several resources, including Flora of China Official Website and various scientific databases, such as PubMed, SciFinder, the Web of Science, Science Direct, and China Knowledge Resource Integrated (CNKI). Advances in the botanical, ethnomedicinal, phytochemical, and pharmacological studies of this genus are reviewed in this paper. Results showed that more than 440 compounds, including C21 steroids, steroidal saponins, alkaloids, flavonoids and terpene, have been isolated and identified from plants up to now. In vivo and in vitro studies have shown that plants possess an array of biological activities, including anti-tumor, neuroprotective and anti-fungal effects. Popular traditional prescription of sp. was also summed up in this paper. However, many species have received little or no attention. Moreover, few reports on the clinical use and toxic effects of sp. are available. Further attention should be focused on the study of these species to gather information on their respective toxicology data and relevant quality-control measures and clinical value of the crude extracts, active compounds, and bioactive metabolites from this genus. Further research on sp. should be conducted, and bioactivity-guided isolation strategies should be emphasized. In addition, systematic studies of the chemical composition of plants should be enhanced.
属属于萝藦科,该科包含超过 200 种分布于全球各地的物种。在中国医学实践中,许多含有该属植物不同部位的药物(如片剂和粉末)被用于治疗蛇咬伤、瘀伤、成骨细胞、类风湿关节炎和肿瘤。通过使用多个资源,包括中国植物志官方网站和各种科学数据库,如 PubMed、SciFinder、Web of Science、Science Direct 和中国知识资源综合(CNKI),对属的原始文章进行了搜索。本文综述了该属植物的植物学、民族医学、植物化学和药理学研究进展。结果表明,迄今为止,已从植物中分离鉴定出超过 440 种化合物,包括 C21 甾体、甾体皂苷、生物碱、黄酮类和萜类化合物。体内和体外研究表明,植物具有多种生物活性,包括抗肿瘤、神经保护和抗真菌作用。本文还总结了该属植物的一些常用传统方剂。然而,许多属的植物仍未受到关注。此外,关于该属植物的临床应用和毒性作用的报道很少。应进一步关注这些物种的研究,以收集有关其各自毒理学数据以及该属粗提取物、活性化合物和生物活性代谢物的相关质量控制措施和临床价值的信息。应进一步研究该属植物,并强调基于生物活性的分离策略。此外,应加强对植物化学成分的系统研究。